
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59DDF5926450633ADDF50027709EFB.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="oncotarget">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5464838/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Oncotarget">
<meta name="citation_title" content="A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma">
<meta name="citation_author" content="Priscila H Goncalves">
<meta name="citation_author_institution" content="Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA">
<meta name="citation_author" content="Lance K Heilbrun">
<meta name="citation_author_institution" content="Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA">
<meta name="citation_author" content="Michael T Barrett">
<meta name="citation_author_institution" content="Mayo Clinic Arizona, Scottsdale, AZ, USA">
<meta name="citation_author" content="Shivaani Kummar">
<meta name="citation_author_institution" content="Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA">
<meta name="citation_author_institution" content="Current address: Stanford University, Palo Alto, CA, USA">
<meta name="citation_author" content="Aaron R Hansen">
<meta name="citation_author_institution" content="Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada">
<meta name="citation_author" content="Lillian L Siu">
<meta name="citation_author_institution" content="Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada">
<meta name="citation_author" content="Richard L Piekarz">
<meta name="citation_author_institution" content="Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA">
<meta name="citation_author" content="Ammar W Sukari">
<meta name="citation_author_institution" content="Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA">
<meta name="citation_author" content="Joseph Chao">
<meta name="citation_author_institution" content="Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA">
<meta name="citation_author" content="Mary Jo Pilat">
<meta name="citation_author_institution" content="Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA">
<meta name="citation_author_institution" content="Eugene Applebaum College of Pharmacy and Health Sciences, Physician Assistant Studies, Wayne State University, Detroit, MI, USA">
<meta name="citation_author" content="Daryn W Smith">
<meta name="citation_author_institution" content="Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA">
<meta name="citation_author" content="Lindsay Casetta">
<meta name="citation_author_institution" content="Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA">
<meta name="citation_author" content="Scott A Boerner">
<meta name="citation_author_institution" content="Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA">
<meta name="citation_author_institution" content="Current address: Yale Cancer Center, New Haven, CT, USA">
<meta name="citation_author" content="Alice Chen">
<meta name="citation_author_institution" content="Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA">
<meta name="citation_author" content="Elizabeth Lenkiewicz">
<meta name="citation_author_institution" content="Mayo Clinic Arizona, Scottsdale, AZ, USA">
<meta name="citation_author" content="Smriti Malasi">
<meta name="citation_author_institution" content="Mayo Clinic Arizona, Scottsdale, AZ, USA">
<meta name="citation_author" content="Patricia M LoRusso">
<meta name="citation_author_institution" content="Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA">
<meta name="citation_author_institution" content="Current address: Yale Cancer Center, New Haven, CT, USA">
<meta name="citation_publication_date" content="2017 Mar 22">
<meta name="citation_volume" content="8">
<meta name="citation_issue" content="20">
<meta name="citation_firstpage" content="32918">
<meta name="citation_doi" content="10.18632/oncotarget.16464">
<meta name="citation_pmid" content="28415633">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5464838/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5464838/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5464838/pdf/oncotarget-08-32918.pdf">
<meta name="description" content="Vorinostat is a histone deacetylase inhibitor (HDACi). Based on a confirmed partial response (PR) in an adenoid cystic carcinoma (ACC) patient treated with vorinostat in a prior phase 1 trial, we initiated this phase 2 trial. Methods: Vorinostat was ...">
<meta name="og:title" content="A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Vorinostat is a histone deacetylase inhibitor (HDACi). Based on a confirmed partial response (PR) in an adenoid cystic carcinoma (ACC) patient treated with vorinostat in a prior phase 1 trial, we initiated this phase 2 trial. Methods: Vorinostat was ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5464838/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="5464838">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.18632/oncotarget.16464"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/oncotarget-08-32918.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC5464838%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/5464838/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/5464838/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC5464838/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-oncotarget.gif" alt="Oncotarget logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Oncotarget" title="Link to Oncotarget" shape="default" href="https://www.oncotarget.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Oncotarget</button></div>. 2017 Mar 22;8(20):32918–32929. doi: <a href="https://doi.org/10.18632/oncotarget.16464" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.18632/oncotarget.16464</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Oncotarget%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Oncotarget%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Oncotarget%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Oncotarget%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Goncalves%20PH%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Priscila H Goncalves</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Priscila H Goncalves</span></h3>
<div class="p">
<sup>1</sup> Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Goncalves%20PH%22%5BAuthor%5D" class="usa-link"><span class="name western">Priscila H Goncalves</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Heilbrun%20LK%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Lance K Heilbrun</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Lance K Heilbrun</span></h3>
<div class="p">
<sup>1</sup> Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Heilbrun%20LK%22%5BAuthor%5D" class="usa-link"><span class="name western">Lance K Heilbrun</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Barrett%20MT%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Michael T Barrett</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Michael T Barrett</span></h3>
<div class="p">
<sup>2</sup> Mayo Clinic Arizona, Scottsdale, AZ, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Barrett%20MT%22%5BAuthor%5D" class="usa-link"><span class="name western">Michael T Barrett</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kummar%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Shivaani Kummar</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Shivaani Kummar</span></h3>
<div class="p">
<sup>4</sup> Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA</div>
<div class="p">
<sup>8</sup> Current address: Stanford University, Palo Alto, CA, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kummar%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shivaani Kummar</span></a>
</div>
</div>
<sup>4,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hansen%20AR%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Aaron R Hansen</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Aaron R Hansen</span></h3>
<div class="p">
<sup>3</sup> Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hansen%20AR%22%5BAuthor%5D" class="usa-link"><span class="name western">Aaron R Hansen</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Siu%20LL%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Lillian L Siu</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Lillian L Siu</span></h3>
<div class="p">
<sup>3</sup> Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Siu%20LL%22%5BAuthor%5D" class="usa-link"><span class="name western">Lillian L Siu</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Piekarz%20RL%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Richard L Piekarz</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Richard L Piekarz</span></h3>
<div class="p">
<sup>4</sup> Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Piekarz%20RL%22%5BAuthor%5D" class="usa-link"><span class="name western">Richard L Piekarz</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sukari%20AW%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Ammar W Sukari</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Ammar W Sukari</span></h3>
<div class="p">
<sup>1</sup> Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sukari%20AW%22%5BAuthor%5D" class="usa-link"><span class="name western">Ammar W Sukari</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chao%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Joseph Chao</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Joseph Chao</span></h3>
<div class="p">
<sup>5</sup> Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chao%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Joseph Chao</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pilat%20MJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Mary Jo Pilat</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Mary Jo Pilat</span></h3>
<div class="p">
<sup>1</sup> Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA</div>
<div class="p">
<sup>6</sup> Eugene Applebaum College of Pharmacy and Health Sciences, Physician Assistant Studies, Wayne State University, Detroit, MI, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pilat%20MJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Mary Jo Pilat</span></a>
</div>
</div>
<sup>1,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Smith%20DW%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Daryn W Smith</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Daryn W Smith</span></h3>
<div class="p">
<sup>1</sup> Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Smith%20DW%22%5BAuthor%5D" class="usa-link"><span class="name western">Daryn W Smith</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Casetta%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Lindsay Casetta</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Lindsay Casetta</span></h3>
<div class="p">
<sup>1</sup> Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Casetta%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lindsay Casetta</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boerner%20SA%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Scott A Boerner</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Scott A Boerner</span></h3>
<div class="p">
<sup>1</sup> Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA</div>
<div class="p">
<sup>7</sup> Current address: Yale Cancer Center, New Haven, CT, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boerner%20SA%22%5BAuthor%5D" class="usa-link"><span class="name western">Scott A Boerner</span></a>
</div>
</div>
<sup>1,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Alice Chen</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Alice Chen</span></h3>
<div class="p">
<sup>4</sup> Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alice Chen</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lenkiewicz%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Elizabeth Lenkiewicz</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Elizabeth Lenkiewicz</span></h3>
<div class="p">
<sup>2</sup> Mayo Clinic Arizona, Scottsdale, AZ, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lenkiewicz%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elizabeth Lenkiewicz</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Malasi%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Smriti Malasi</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Smriti Malasi</span></h3>
<div class="p">
<sup>2</sup> Mayo Clinic Arizona, Scottsdale, AZ, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Malasi%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Smriti Malasi</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22LoRusso%20PM%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Patricia M LoRusso</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Patricia M LoRusso</span></h3>
<div class="p">
<sup>1</sup> Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA</div>
<div class="p">
<sup>7</sup> Current address: Yale Cancer Center, New Haven, CT, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22LoRusso%20PM%22%5BAuthor%5D" class="usa-link"><span class="name western">Patricia M LoRusso</span></a>
</div>
</div>
<sup>1,</sup><sup>7</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="A1">
<sup>1</sup> Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA</div>
<div id="A2">
<sup>2</sup> Mayo Clinic Arizona, Scottsdale, AZ, USA</div>
<div id="A3">
<sup>3</sup> Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada</div>
<div id="A4">
<sup>4</sup> Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA</div>
<div id="A5">
<sup>5</sup> Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA</div>
<div id="A6">
<sup>6</sup> Eugene Applebaum College of Pharmacy and Health Sciences, Physician Assistant Studies, Wayne State University, Detroit, MI, USA</div>
<div id="A7">
<sup>7</sup> Current address: Yale Cancer Center, New Haven, CT, USA</div>
<div id="A8">
<sup>8</sup> Current address: Stanford University, Palo Alto, CA, USA</div>
<div class="author-notes p"><div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline"><strong>Correspondence to:</strong> Priscila H. Goncalves, <span>priscila.goncalves@nih.gov</span></p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2017 Feb 9; Accepted 2017 Mar 14; Collection date 2017 May 16.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright: © 2017 Goncalves et al.</div>
<p>This article is distributed under the terms of the <a href="http://creativecommons.org/licenses/by/3.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC5464838  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/28415633/" class="usa-link">28415633</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Purpose</h3>
<p>Vorinostat is a histone deacetylase inhibitor (HDACi). Based on a confirmed partial response (PR) in an adenoid cystic carcinoma (ACC) patient treated with vorinostat in a prior phase 1 trial, we initiated this phase 2 trial. Methods: Vorinostat was administered orally 400 mg daily, 28 day cycles. The primary objective was to evaluate response rate (RR). Exploratory studies included whole exome sequencing (WES) of selected patients.</p></section><section id="sec2"><h3 class="pmc_sec_title">Results</h3>
<p>Thirty patients were enrolled. Median age of patients was 53 years (range 21–73). Median number of cycles was 5 (range 1-66). Lymphopenia (<em>n</em> = 5), hypertension (<em>n</em> = 3), oral pain (<em>n</em> = 2), thromboembolic events (<em>n</em> = 2) and fatigue (<em>n</em> = 2) were the only grade 3 adverse events (AEs) that occurred in more than 1 patient. Eleven patients were dose reduced secondary to drug-related AEs. Two patients had a partial response (PR), with response durations of 53 and 7.2 months. One patient had a minor response with a decrease in ascites (for 19 cycles). Stable disease was the best response in 27 patients. Targeted and WES of 8 patients in this trial identified mutations in chromatin remodeling genes highlighting the role of the epigenome in ACC. Conclusion: Vorinostat demonstrated efficacy in patients with ACC supporting the inclusion of HDACi in future studies to treat ACC.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> adenoid cystic, salivary gland tumor, vorinostat, suberoylanilide hydroxamic acid, SAHA</p></section></section><section id="s1"><h2 class="pmc_sec_title">INTRODUCTION</h2>
<p>Adenoid cystic carcinoma (ACC) is a rare type of cancer, most commonly originating from the salivary glands, with an indolent behavior but a high propensity to metastasize [<a href="#R1" class="usa-link" aria-describedby="R1">1</a>]. Surgery with wide resection is the mainstay of treatment for localized ACC. A watch and wait approach is appropriate if a patient has metastases, especially if confined to the lungs with minimal symptoms [<a href="#R2" class="usa-link" aria-describedby="R2">2</a>].</p>
<p>Several anti-cancer agents have been studied to treat metastatic ACC, however none have shown a robust response rate, with stable disease (SD) being the most common reported outcome. SD duration over 6 months is a common metric used in ACC trials, varying among different agents, with reported ranges of 30–60% (reviewed in [<a href="#R3" class="usa-link" aria-describedby="R3">3</a>]). Currently, there is no Food and Drug Administration (FDA) approved agent for the treatment of ACC.</p>
<p>Suberoylanilide hydroxamic acid (SAHA), also known as vorinostat, is a small molecule inhibitor of histone deacetylase (HDAC). Two patients with ACC on a previously published National Cancer Institute (NCI) trial evaluating vorinostat in patients with advanced cancers and liver dysfunction experienced significant radiological and/or clinical improvement [<a href="#R4" class="usa-link" aria-describedby="R4">4</a>]. Additionally, recent next generation sequencing (NGS) studies of ACC have demonstrated a low mutation rate with few recurring single gene mutations converging on regulators of chromatin remodeling [<a href="#R5" class="usa-link" aria-describedby="R5">5</a>, <a href="#R6" class="usa-link" aria-describedby="R6">6</a>].</p>
<p>Based on these encouraging findings, we undertook this multi-institutional phase 2 trial of vorinostat in patients with locally advanced or metastatic ACC.</p></section><section id="s2"><h2 class="pmc_sec_title">RESULTS</h2>
<section id="s2_1"><h3 class="pmc_sec_title">Baseline demographics and patient characteristics</h3>
<p>Thirty patients were enrolled over 22 months. As shown in Table <a href="#T1" class="usa-link">1</a>, 19 patients (63%) were female and 24 (80%) were Caucasian. The median age was 53 years (range 21–73), 21 had a performance status of 1 and 19 were chemo-naïve. Twenty-eight had metastatic disease and 2 patients had locally advanced disease. While not an eligibility criterion, 27 out of 30 patients had radiographic disease progression before study entry.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">Table 1. Baseline demographics and disease characteristics (N = 30).</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="all">
<thead><tr>
<th align="center" valign="middle" rowspan="1" colspan="1">Characteristics</th>
<th align="center" valign="middle" rowspan="1" colspan="1">No. of Patients</th>
<th align="center" valign="middle" rowspan="1" colspan="1">%</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"><strong>Race</strong></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"> White</td>
<td align="center" valign="middle" rowspan="1" colspan="1">24</td>
<td align="center" valign="middle" rowspan="1" colspan="1">80</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"> African-American</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">10</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"> Asian</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">6.7</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"> Middle Eastern</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3.3</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"><strong>Sex</strong></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"> Male</td>
<td align="center" valign="middle" rowspan="1" colspan="1">11</td>
<td align="center" valign="middle" rowspan="1" colspan="1">37</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"> Female</td>
<td align="center" valign="middle" rowspan="1" colspan="1">19</td>
<td align="center" valign="middle" rowspan="1" colspan="1">63</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"><strong>ECOG PS</strong></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"> 0</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7</td>
<td align="center" valign="middle" rowspan="1" colspan="1">23</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"> 1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">21</td>
<td align="center" valign="middle" rowspan="1" colspan="1">70</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"> 2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"><strong>Age (years)</strong></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"> Median (range)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">53 (21–73)</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"><strong>Disease Site</strong></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"> Metastatic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">28</td>
<td align="center" valign="middle" rowspan="1" colspan="1">93</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"> Locally Advanced</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"><strong>Prior Chemotherapy</strong></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"> Chemo-naive</td>
<td align="center" valign="middle" rowspan="1" colspan="1">19</td>
<td align="center" valign="middle" rowspan="1" colspan="1">63</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p8"><p>ECOG PS- Eastern Cooperative Oncology Group performance status</p></div></div></section></section><section id="s2_2"><h3 class="pmc_sec_title">Efficacy</h3>
<p>Partial responses by Response Evaluation Criteria in Solid Tumors (RECIST) were observed in two patients. These responses were not immediate. One patient had a decrease in the size of lung nodules achieving a partial response (PR) at cycle 8 and the other patient experienced reduction in size and number of liver and lung lesions achieving a PR by cycle 10 (Figure <a href="#F1" class="usa-link">1</a>). One of the patients with PR had surgery and radiation as prior therapies and the other patient with PR also received surgery, radiation and one systemic chemotherapy prior to enrolling in this trial. While stable disease (SD) was the best response in 27 patients, 20 patients demonstrated a decrease in the size of their tumors (Figure <a href="#F2" class="usa-link">2</a>). Another patient had improvement in ascites from cycle 6 through cycle 20 (minor response). The overall response rate (RR) was 7% with a clinical benefit rate (PR+SD) of 97% (Table <a href="#T2" class="usa-link">2</a>). Anecdotal improvement in symptoms was also noted in 3 patients despite SD by RECIST. Three patients received extensive therapy to 56, 62 and 66 cycles.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1. Baseline (top) and Cycle 13 (bottom) computer tomography (CT) scan (chest and abdomen) from a patient who had a partial response and a duration of 7.2 months.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5464838_oncotarget-08-32918-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44f4/5464838/02f281610cb1/oncotarget-08-32918-g001.jpg" loading="lazy" height="521" width="751" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2. Waterfall plot of the percent change from baseline to best response in the sum of the longest diameters (SLD) of the index lesions for 29 treated patients.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5464838_oncotarget-08-32918-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44f4/5464838/f57b246af183/oncotarget-08-32918-g002.jpg" loading="lazy" height="495" width="745" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>For one treated patient the follow-up CT was not available. The horizontal dashed lines indicate the thresholds for partial response (PR: ≥ 30% decrease in SLD) and for progressive disease (PD: ≥ 20% increase in SLD).</p></figcaption></figure><section class="tw xbox font-sm" id="T2"><h4 class="obj_head">Table 2. Response rate (among N = 30 treated patients).</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="all">
<thead><tr>
<th align="center" valign="middle" rowspan="1" colspan="1">Response Category</th>
<th align="center" valign="middle" rowspan="1" colspan="1">No. of Patients (%)</th>
<th align="center" valign="middle" rowspan="1" colspan="1">95% Confidence Interval</th>
</tr></thead>
<tbody>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"><strong>Partial Response (PR)</strong></td>
<td align="center" valign="middle" rowspan="1" colspan="1">2/30 (7%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2%–21%</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"><strong>Stable Disease (SD)</strong></td>
<td align="center" valign="middle" rowspan="1" colspan="1">27/30 (90%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">74%–97%</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"><strong>Clinical Benefit (PR+SD)</strong></td>
<td align="center" valign="middle" rowspan="1" colspan="1">29/30 (97%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">83%–99%</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1"><strong>Progressive Disease</strong></td>
<td align="center" valign="middle" rowspan="1" colspan="1">1/30 (4%)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1%–17%</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="s2_3"><h3 class="pmc_sec_title">Toxicity</h3>
<p>The most frequent grade 3 toxicities were lymphopenia (7/30 = 23%), hypertension and fatigue (3/30 = 10% each), headache, oral pain and thromboembolic event (2/30 = 7% each) (Table <a href="#T3" class="usa-link">3</a>). Grade 4 bronchopulmonary hemorrhage and hypoxia occurred in 3% (1 patient each), but neither was drug-related. Eleven patients were dose reduced, 10 patients were reduced by one dose level to 300mg daily and 1 patient to 300 mg once a day for 5 days with 2 days off (reduction of two dose levels). Three patients discontinued treatment due to toxicity.</p>
<section class="tw xbox font-sm" id="T3"><h4 class="obj_head">Table 3. Grade 3 or 4 toxicities experienced by at least 1 patient (N = 30 treated patients).</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="all">
<thead>
<tr>
<th rowspan="2" align="center" valign="bottom" colspan="1">Type of toxicity <sup>a</sup>
</th>
<th colspan="5" align="center" valign="middle" rowspan="1">Worst grade experienced</th>
</tr>
<tr>
<th align="center" valign="middle" rowspan="1" colspan="1">0</th>
<th align="center" valign="middle" rowspan="1" colspan="1">1</th>
<th align="center" valign="middle" rowspan="1" colspan="1">2</th>
<th align="center" valign="middle" rowspan="1" colspan="1">3</th>
<th align="center" valign="middle" rowspan="1" colspan="1">4</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Bronchopulmonary hemorrhage</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Hypoxia</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Lymphopenia</td>
<td align="center" valign="middle" rowspan="1" colspan="1">13</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Hypertension</td>
<td align="center" valign="middle" rowspan="1" colspan="1">15</td>
<td align="center" valign="middle" rowspan="1" colspan="1">5</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Fatigue</td>
<td align="center" valign="middle" rowspan="1" colspan="1">9</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12</td>
<td align="center" valign="middle" rowspan="1" colspan="1">6</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Headache</td>
<td align="center" valign="middle" rowspan="1" colspan="1">21</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Oral pain</td>
<td align="center" valign="middle" rowspan="1" colspan="1">27</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">Thrombo-embolic event</td>
<td align="center" valign="middle" rowspan="1" colspan="1">26</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p12"><p><sup>a</sup>There were 14 other miscellaneous toxicities whose worst Grade was 3, and they occurred in only 1 patient: appendicitis, menorrhagia, atelectasis, bronchial obstruction, pneumonia, lung infection, wound complication, thrombocytopenia, diarrhea, cataract, oral mucositis, hypophosphatemia, increased lymphocyte count, and non-cardiac chest pain.</p></div></div></section></section><section id="s2_4"><h3 class="pmc_sec_title">Time to event end-points</h3>
<p>Time to tumor response (TTR) was 7.7 and 10.0 months in the 2 patients who achieved PR. The duration of their response was 53 and 7.2 months, respectively, with the former patient still receiving study drug. Prior to study entry, 27 (90%) of the 30 patients had documented progressive disease on their most recent scans. The median follow-up among the censored patients was 8.0 months for stable disease duration (SDD), 10.0 months for progression free survival (PFS), and 11.5 months for overall survival (OS). The 6 month rates for SDD, PFS, and OS were 75%, 72%, and 94%, respectively. The 12 month rates for SDD, PFS and OS were 45%, 46%, and 88%, respectively. (<a href="#SD1" class="usa-link">Supplementary Table 1</a> - Supplementary Appendix). The median PFS and SDD were both 11.4 months, and the median OS has not been reached. The estimated SDD and PFS distributions are shown in the Supplementary Appendix (<a href="#SD1" class="usa-link">Supplementary Figures 1 and 2</a>, respectively).</p></section><section id="s2_5"><h3 class="pmc_sec_title">Exploratory studies</h3>
<p>We hypothesized that the variation in clinical response to vorinostat (“responders” or “non-responders”- Table <a href="#T4" class="usa-link">4</a>) is associated with the presence or absence of driver mutations including those targeting chromatin remodeling genes involved in the regulation of the cancer epigenome. To test our hypothesis, we used both targeted and whole exome sequencing to survey the mutational landscape of each tumor.</p>
<section class="tw xbox font-sm" id="T4"><h4 class="obj_head">Table 4. Selected responses to vorinostat and mutations identified.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="box" rules="all">
<thead><tr>
<th align="center" valign="top" rowspan="1" colspan="1"></th>
<th align="center" valign="top" rowspan="1" colspan="1">001-002<sup>a,b</sup>
</th>
<th align="center" valign="top" rowspan="1" colspan="1">001-004<sup>a,b</sup>
</th>
<th align="center" valign="top" rowspan="1" colspan="1">001-006<sup>a,b</sup>
</th>
<th align="center" valign="top" rowspan="1" colspan="1">003-014<sup>a,b</sup>
</th>
<th align="center" valign="top" rowspan="1" colspan="1">003-015<sup>b</sup>
</th>
<th align="center" valign="top" rowspan="1" colspan="1">003-018<sup>b</sup>
</th>
<th align="center" valign="top" rowspan="1" colspan="1">004-023<sup>b</sup>
</th>
<th align="center" valign="top" rowspan="1" colspan="1">003-027<sup>a,b</sup>
</th>
<th align="center" valign="top" rowspan="1" colspan="1"></th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Clinical Response/Number of Cycles Received</td>
<td align="center" valign="top" rowspan="1" colspan="1">Decrease in neurological pain - 44 cycles</td>
<td align="center" valign="top" rowspan="1" colspan="1">Partial response by RECIST- 66 cycles</td>
<td align="center" valign="top" rowspan="1" colspan="1">Decrease in ascites and abdominal girth −19 cycles</td>
<td align="center" valign="top" rowspan="1" colspan="1">Prolonged stable disease – 57 cycles</td>
<td align="center" valign="top" rowspan="1" colspan="1">Prolonged stable disease −51 cycles</td>
<td align="center" valign="top" rowspan="1" colspan="1">Progressed on study after 2 cycles</td>
<td align="center" valign="top" rowspan="1" colspan="1">Prolonged stable disease −22 cycles</td>
<td align="center" valign="top" rowspan="1" colspan="1">Progressed on study after 3 cycles</td>
<td align="center" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">ARID3A</td>
<td align="left" valign="middle" style="background-color:#00b0f0" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td rowspan="13" align="left" valign="middle" colspan="1">Chromatin remodeling</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">ARID4B</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">BRD1</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">BRD3</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">KDM4D</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">KDM6A</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ffff00" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">KMT2A</td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">KMT2E</td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">FAM129B</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#00b050" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">PHF1</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">PHF2</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">PRDM1</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">PRDM16</td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">SMARCA2</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr><td colspan="10" align="left" valign="middle" rowspan="1"></td></tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">CDK8</td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td rowspan="14" align="left" valign="middle" colspan="1">Cell signaling</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">DLL1</td>
<td align="left" valign="middle" style="background-color:#00b0f0" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">ESR1</td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">FAT3</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">FZD10</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ffff00" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">JAG1</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">MAP3K1</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#00b0f0" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">MTOR</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#00b050" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">NOTCH1</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">OGT</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#00b0f0" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">PIK3CA</td>
<td align="left" valign="middle" style="background-color:#00b050" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">RASA3</td>
<td align="left" valign="middle" style="background-color:#00b050" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">RHBDF1</td>
<td align="left" valign="middle" style="background-color:#ffff00" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">SIK3</td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr><td colspan="10" align="left" valign="middle" rowspan="1"></td></tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">CDC25C</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td rowspan="9" align="left" valign="middle" colspan="1">Cell cycle DNA damage</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">ERCC2</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">FANCC</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">MLF1</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ffff00" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">N4BP2</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ffff00" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">PLK4</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">POLE</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ff0000" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">RAD52</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ffff00" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">SH2D4A</td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" style="background-color:#ffff00" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
<td align="left" valign="middle" rowspan="1" colspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p15"><p>RECIST- Response Evaluation Criteria in Solid Tumors; Yellow- Nonsense; Red- Missense; Blue- Frame shift indel; Green- Essential splice, <sup>a</sup>- Exome, <sup>b</sup>- 10-gene panel.</p></div></div></section></section><section id="s2_6"><h3 class="pmc_sec_title">Exploratory studies results</h3>
<section id="s2_6_1"><h4 class="pmc_sec_title">“Responders”</h4>
<p>We sequenced the exomes from 4 of these patients (001–002, 001–004, 001–006, 003–014). In each case we found somatic mutations of interest after filtering. These and 2 additional responder cases (003–015, 004–023) were screened with our 10 gene panel. A striking observation was the lack of recurring gene specific mutations in these 4 cases (Table <a href="#T4" class="usa-link">4</a>). However, recurring cell pathways and processes were targeted.</p></section><section id="s2_6_2"><h4 class="pmc_sec_title">Patient 001–002</h4>
<p>There were a series of unique somatic variants detected in this tumor. Notably these converged on chromatin remodeling, transcriptional regulation, and cell signaling. The DNA binding factor <em>ARID3A</em> has been implicated in RB1/E2F mediated control of cell cycle progression while <em>KMT2E</em> and <em>KMT2A</em> belong to the myeloid/lymphoid or mixed-lineage leukemia (MLL) class of epigenetic writers (<a href="#SD1" class="usa-link">Supplementary Figure 3</a> - Supplementary Appendix). In addition, mutations targeted regulators of RAS (<em>RASA3</em>), EGFR (<em>RHBDF1</em>), and estrogen (<em>ESR1</em>) and NOTCH (<em>DLL1</em>) signaling.</p></section><section id="s2_6_3"><h4 class="pmc_sec_title">Patient 001–004</h4>
<p>Variants in genes associated with chromatin remodeling and DNA repair were detected. These included <em>BRCA1</em><sup>Q356R</sup>, <em>BRCA2</em><sup>N372H</sup>, and <em>EZH2</em><sup>D185H</sup>. However, each of these variants appears in dbSNP, has a population frequency of &gt; 5%, and has not been associated with an increased cancer risk [<a href="#R7" class="usa-link" aria-describedby="R7">7</a>]. We also detected <em>ATM</em><sup>R720H</sup> in the tumor tissue. However, the targeted amino acids in both wild type and this somatic variant have positive charge side chains. Thus, the functional effects of this variant on ATM activity are not clear. In contrast the <em>MLF1</em><sup>L120</sup>* and <em>N4BP2</em><sup>K76</sup>* non sense variants have low or absent reported allele frequencies. <em>MLF1</em> (Myeloid leukemia factor 1) is a transcription factor that prevents cells from exiting the cell cycle through suppression of CDKN1B/p27Kip1 levels and activation of TP53 [<a href="#R8" class="usa-link" aria-describedby="R8">8</a>]. Mutations in <em>TP53</em> have been reported in ACC [<a href="#R6" class="usa-link" aria-describedby="R6">6</a>]. However, we did not observe any <em>TP53</em> mutations in the current study. Thus the <em>MLF1</em><sup>L120</sup>* mutation may provide a novel mechanism to target <em>TP53</em> mediated repair and cell cycle checkpoint functions in ACC. <em>N4BP2</em> (NEDD4 binding protein 2) has 5′-polynucleotide kinase and nicking endonuclease activity and may play a role in DNA repair or recombination [<a href="#R9" class="usa-link" aria-describedby="R9">9</a>].</p></section><section id="s2_6_4"><h4 class="pmc_sec_title">Patient 001–006</h4>
<p>We identified two additional novel ACC mutations (<em>SH2D4A</em><sup>R237</sup>*, <em>FZD10</em><sup>G345</sup>*) that have previously been reported in colon and gastric cancer [<a href="#R10" class="usa-link" aria-describedby="R10">10</a>–<a href="#R13" class="usa-link" aria-describedby="R13">13</a>]. <em>SH2D4A</em> inhibits estrogen-induced cell proliferation by competing with phospholipase C, gamma 2 (PLCG) for binding to ESR1, blocking the effect of estrogen on PLCG and repressing estrogen-induced proliferation [<a href="#R12" class="usa-link" aria-describedby="R12">12</a>]. It may play a role in T-cell development and function. Both of these unique <em>SH2D4A</em> and <em>FZD10</em> mutations were validated in our targeted resequencing analyses. The Drosophila frizzled polarity gene homolog 10 (<em>FZD10</em>) is a member of the G protein coupled receptor (GPCR) superfamily, exhibiting characteristics of a WNT receptor [<a href="#R13" class="usa-link" aria-describedby="R13">13</a>]. We also detected variants in chromatin remodeler genes including <em>ARID4B</em><sup>T84R</sup> and <em>PHF1</em><sup>E128Q</sup>. The latter gene encodes a Polycomb group protein that is a component of a histone H3 lysine-27 (H3K27)-specific methyltransferase complex, and functions in transcriptional repression of homeotic genes [<a href="#R14" class="usa-link" aria-describedby="R14">14</a>]. The protein is also recruited to double-strand breaks, and reduced protein levels results in X-ray sensitivity and increased homologous recombination [<a href="#R15" class="usa-link" aria-describedby="R15">15</a>, <a href="#R16" class="usa-link" aria-describedby="R16">16</a>]. Recurring chromosomal aberrations involving <em>PHF1</em> may be a cause of endometrial stromal tumors [<a href="#R17" class="usa-link" aria-describedby="R17">17</a>, <a href="#R18" class="usa-link" aria-describedby="R18">18</a>]. In addition, we detected variants in the DNA damage checkpoint regulators <em>ATR</em><sup>Phe926Leu</sup> and <em>RAD52</em><sup>Y415</sup>*.</p></section><section id="s2_6_5"><h4 class="pmc_sec_title">Patient 003–014</h4>
<p>The mutations in this tumor included 3 predicted high impact mutations in <em>MTOR</em> a regulator of stress response, <em>OGT</em> a glycosyltransferase that modifies a broad range of targets including H2B, AKT1, EZH2, PFKL, KMT2E/MLL5, MAPT/TAU and HCFC1, and <em>FAM129B</em> a negative regulator of apoptosis [<a href="#R19" class="usa-link" aria-describedby="R19">19</a>]. Additional mutations included the cell cycle regulator <em>CDC25C</em>, the chromatin regulators <em>PHF2</em> and <em>BRD1</em>, and the NOTCH1 ligand <em>JAG1</em>. The latter is a transcriptional target of MYB [<a href="#R20" class="usa-link" aria-describedby="R20">20</a>].</p></section><section id="s2_6_6"><h4 class="pmc_sec_title">Patients 003–015 and 004–023</h4>
<p>Both patients were screened with our 10 gene panel. We detected a somatic variant in <em>SMARCA2</em> in 003–015 adding to the list of unique mutations in chromatin regulators. In addition, we detected a <em>PIK3CA</em> mutation in 004–023. Mutations in both these genes have been previously reported in ACC [<a href="#R5" class="usa-link" aria-describedby="R5">5</a>, <a href="#R6" class="usa-link" aria-describedby="R6">6</a>].</p></section><section id="s2_6_7"><h4 class="pmc_sec_title">“Non-responders”</h4>
<p>We obtained WES data from one of four non-responders (003–027). Targeted resequencing provided additional data for a second non- responder (003–018) and validation of the KDM6A mutation detected in the whole exome results (Table <a href="#T4" class="usa-link">4</a>).</p></section><section id="s2_6_8"><h4 class="pmc_sec_title">Patient 003–027</h4>
<p>A striking finding was the presence of a mutation in the <em>NOTCH1</em> receptor (<a href="#SD1" class="usa-link">Supplementary Figure 3</a>). This gain of function mutation destabilizes the heterodimerization domain of the receptor. It results in ligand-independent cleavage of Notch1 at site S2 and subsequent receptor activation. This mutation is a recurrent driver of T cell ALL [<a href="#R21" class="usa-link" aria-describedby="R21">21</a>, <a href="#R22" class="usa-link" aria-describedby="R22">22</a>]. To our knowledge, this is the first report of the association of this recurring mutation in ACC with resistance to vorinostat. We also detected a nonsense mutation in the lysine demethylase <em>KDM6A</em>. Mutations in this lysine demethylase, also known as <em>UTX</em>, have been reported in several cancers and are one of several classes of mutations that are believed to converge on chromatin remodeling in ACC [<a href="#R11" class="usa-link" aria-describedby="R11">11</a>, <a href="#R23" class="usa-link" aria-describedby="R23">23</a>]. Pathogenic KDM6A variants disrupt histone structure [<a href="#R23" class="usa-link" aria-describedby="R23">23</a>]. This latter mutation was unique to non-responder 003–027 and was validated by targeted resequencing with our 10-gene panel.</p></section><section id="s2_6_9"><h4 class="pmc_sec_title">Patient 003–018</h4>
<p>The exome data for the tumor sample failed overall quality metrics including coverage and percent target bases. Targeted resequencing was of sufficient quality for this tumor normal pair however we did not identify any somatic variants in the 10-gene panel.</p></section></section></section><section id="s3"><h2 class="pmc_sec_title">DISCUSSION</h2>
<p>ACC is a rare neoplasm with an initial indolent pace. However, once it becomes metastatic, it runs an inexorable, albeit slow growing course with poor and short-lived responses to available treatments [<a href="#R2" class="usa-link" aria-describedby="R2">2</a>, <a href="#R24" class="usa-link" aria-describedby="R24">24</a>].</p>
<p>In our study we saw 2 PRs by RECIST out of 30 patients treated with vorinostat. Both responses occurred late into treatment after 8 and 10 cycles. A third patient had a minor response with reduction in ascites, and eliminated the need for therapeutic paracentesis. Anedoctal improvement in symptoms was also observed in an additional 3 patients (decreased pain, improvement in shortness of breath, improvement in eye movement, and improvement in fatigue) with SD by RECIST. Of note, 20 patients demonstrated a decrease in the size of their tumors. Additionally, 2 patients with ACC were treated with vorinostat in a prior NCI liver dysfunction trial and experienced significant clinical and radiological improvement. (decrease in size of liver lesions and normalization of liver enzymes from moderate liver dysfunction) [<a href="#R4" class="usa-link" aria-describedby="R4">4</a>]. In the patients from the liver dysfunction trial, the clinical improvement (less fatigue and pain, weight gain) also started early (after 2–3 cycles) and preceded any radiologic change by several cycles, similar to what we observed in our current trial [<a href="#R4" class="usa-link" aria-describedby="R4">4</a>].</p>
<p>SD duration (SDD) has been described in several trials for patients with ACC [<a href="#R25" class="usa-link" aria-describedby="R25">25</a>–<a href="#R31" class="usa-link" aria-describedby="R31">31</a>]. It is unclear if SD represents a marker of drug activity or simply the indolent behavior of this tumor. However, most ACC studies report SDD of 6 months or more as an endpoint, which may be clinically relevant, especially in view of tumors that were progressing prior to study entry (reviewed in [<a href="#R32" class="usa-link" aria-describedby="R32">32</a>]). In our study, although not required as part of eligibility criteria; 90% (27/30) of the patients had radiological evidence of disease progression prior to enrollment. We observed a 6-month rate of SD of 75%, which is comparable to recent systemic therapeutic interventions studied in this disease [<a href="#R27" class="usa-link" aria-describedby="R27">27</a>–<a href="#R29" class="usa-link" aria-describedby="R29">29</a>, <a href="#R33" class="usa-link" aria-describedby="R33">33</a>].</p>
<p>Currently, response to treatment in most solid tumors is evaluated by measuring the sum of the longest diameter of target lesions according to the RECIST criteria, which has several limitations [<a href="#R34" class="usa-link" aria-describedby="R34">34</a>]. RECIST does not take into account tumor growth dynamics or rate and cannot fully capture response and progression in certain tumor types such as gastrointestinal stromal tumors (GISTs), where which incorporates tumor densities in assessing responses, have been more widely used have been more widely used [<a href="#R35" class="usa-link" aria-describedby="R35">35</a>]. Additionally, in GIST, RECIST underestimates PR rates when compared to CHOI criteria [<a href="#R36" class="usa-link" aria-describedby="R36">36</a>]. A recent study of sorafenib in patients with salivary gland tumors (both ACC and non-ACC) used both RECIST and CHOI criteria to assess responses. It revealed 6 PRs according to RECIST, and 10 PRs according to CHOI (only 2 were concordant with RECIST) [<a href="#R33" class="usa-link" aria-describedby="R33">33</a>]. Also, RECIST may not be the best tool to evaluate tumor response to targeted agents or immune therapy [<a href="#R37" class="usa-link" aria-describedby="R37">37</a>–<a href="#R40" class="usa-link" aria-describedby="R40">40</a>]. The concept of volumetric tumor growth likely is a better method to assess response in such instances [<a href="#R41" class="usa-link" aria-describedby="R41">41</a>]. Volumetric imaging analysis can predict clinical response earlier than RECIST in some cancers and it is also more sensitive than changes in unidimensional diameters [<a href="#R41" class="usa-link" aria-describedby="R41">41</a>]. Considering the late responses observed in some of the patients in the current study, along with early symptomatic improvement, a possible explanation could be that RECIST criteria may not be the best method to monitor ACC patients for response.</p>
<p>Patient reported outcomes (PRO) questionnaires evaluate the impact on patient's functioning and well-being that could likely be caused by the disease and/or its treatment without modification or interpretation by the observer [<a href="#R42" class="usa-link" aria-describedby="R42">42</a>]. Given the slow growing but unrelenting progression of ACC, improvement in PRO is a reasonable measure of clinical benefit. Future trials in patients with ACC should incorporate such questionnaires as endpoints.</p>
<p>Another possibility is that the late responses we observed could be due to an immuno-stimulatory effect of vorinostat, which may take longer to occur and not be evident radiographically as early as with some other therapeutic interventions. Mounting evidence suggests a role for HDACi in modulating the immune system and enhancing efficacy of immunotherapeutic strategies. HDACi have been shown to alter the activation and function of macrophage and dendritic cells [<a href="#R43" class="usa-link" aria-describedby="R43">43</a>]; regulate cytokine production [<a href="#R44" class="usa-link" aria-describedby="R44">44</a>, <a href="#R45" class="usa-link" aria-describedby="R45">45</a>] and upregulate major histocompatibility class I and II molecules [<a href="#R44" class="usa-link" aria-describedby="R44">44</a>, <a href="#R46" class="usa-link" aria-describedby="R46">46</a>].</p>
<p>A feature of the ACC mutational landscape is a low mutational burden with a paucity of common recurring driver mutations typically seen in solid tumors [<a href="#R5" class="usa-link" aria-describedby="R5">5</a>, <a href="#R6" class="usa-link" aria-describedby="R6">6</a>]. For example, <em>TP53</em> mutations, one of the most frequent somatic lesions in solid tumors, have been detected in only 5% of ACC cases studied [<a href="#R6" class="usa-link" aria-describedby="R6">6</a>]. Nevertheless, this represents the second highest incidence of reported somatic variants in ACC. Notably none were detected by either WES or targeted resequencing in the present study. Recent studies suggest that the disparate low frequency mutations in ACC tumors appear to converge on specific pathways notably DNA repair, chromatin regulation, and NOTCH signaling. The exception to this inter-tumor genomic diversity is a translocation targeting c-Myb and NFIB, creating a fusion gene in &gt; 40% of ACC tumors [<a href="#R47" class="usa-link" aria-describedby="R47">47</a>]. Except for low impact variants in UTRs we did not detect any evidence for alterations (mutations or copy number aberrant intervals) associated with this frequent event in our ACC cohort. However, our experimental approach, whole exome sequences for 5 tumors and targeted resequencing that included 3 additional samples, was designed for problematic formalin-fixed, paraffin-embedded (FFPE) samples and was not optimal for detection of genomic lesions associated with translocations.</p>
<p>The whole exome data for the patients in this study highlight the role of DNA repair and chromatin structure regulation in ACC. Mutations, including somatic non sense mutations, targeting key mediators of repair, including RAD52, ATR, and POLQ, were detected in multiple patients. Although none of these mutations were recurring, they converge on well-characterized steps in DNA repair and replication. In addition, we detected mutations targeting different cell signaling pathways including estrogen, NOTCH and the Wnt pathway, as well as PIK3CA/AKT signaling. In each case, unique mutations converged on the pathway. These observations are in agreement with recent whole exome data of ACC [<a href="#R5" class="usa-link" aria-describedby="R5">5</a>, <a href="#R6" class="usa-link" aria-describedby="R6">6</a>]. In addition, the validated mutation in <em>FZD10</em> provides further evidence for a role of aberrant Wnt signaling in ACC [<a href="#R48" class="usa-link" aria-describedby="R48">48</a>]. The most prominent set of mutations was present in multiple chromatin regulating genes (Table <a href="#T4" class="usa-link">4</a>). These included lysine methyltransferases, bromodomain containing proteins, and members of the SWI/SNF chromatin regulator family. Variants in <em>SMARCA2</em> were detected in patient 003–015 however they were either conserved or resulted in an amino acid substitution with the same polarity.</p>
<p>The presence of the <em>KDM6A</em> non sense mutation in patient 003–027 is consistent with studies suggesting that disruption of the epigenome is a driver in a subset of ACC [<a href="#R49" class="usa-link" aria-describedby="R49">49</a>, <a href="#R50" class="usa-link" aria-describedby="R50">50</a>]. Mutations that arise in this region of the protein have been described previously in multiple tumor types. The functional impact of these <em>KDM6A</em> mutations was evaluated via a well-characterized assay for trimethylation at lysine 27 of histone H3 (H3K27me3). Notably abrogation of demethylase activity was observed in cells overexpressing mutant <em>KDM6A</em> but not in those overexpressing wild-type <em>KDM6A</em>. Moreover, whereas wild-type <em>KDM6A</em> suppressed growth, mutants either lost the ability to suppress growth or, in some cases, augmented it (dominant phenotype). Strikingly patient 003–027, whose tumor had a <em>KDM6A</em><sup>R1272X</sup> high impact mutation, progressed after only 3 cycles of vorinostat. Future clinical trials should incorporate sequencing of this and other histone demethylases as a correlative for responses to vorinostat and other epigenetic targeting agents. The presence of well-characterized activating mutations in NOTCH1 supports the role of this pathway in ACC and its potential therapeutic targeting. Notably, mutations targeting NOTCH signaling were present in both responders and non-responders (<a href="#SD1" class="usa-link">Supplementary Figure 3</a>, Table <a href="#T4" class="usa-link">4</a>). Our study adds to the list of mutations reported in ACC and provides further support for the role of mutations targeting chromatin-remodeling genes in this disease.</p>
<p>Our small exploratory study confirms the presence of mutations targeting epigenome regulation in ACC, as 10 out of 11 patients had mutations in chromatin remodeling genes. Notably, a well characterized mutation in the histone demethylase <em>KDM6A/UTX</em> was present in a patient who did not respond to vorinostat. This is in contrast to the presence of mutations in histone methyltransferases (KMT2E and KMT2A), bromodomain containing proteins (BRD1 and BRD3), and members of the SWI/SNF chromatin regulator family (SMARCA2) in responders. However, this non-responder patient (003–027) had an activating <em>NOTCH1</em> mutation, suggesting that it could be the driving mutation in this case, as activating NOTCH1 mutations have been shown to confer a worse prognosis [<a href="#R51" class="usa-link" aria-describedby="R51">51</a>]. The presence of a well-characterized activating mutation in NOTCH1 confirms the role of this signaling pathway in ACC and may provide a therapeutic window in future studies. To advance these observations will require a more standardized tissue collection and processing protocol for correlative studies. Ongoing improvements in NGS technologies will make it feasible to recover more data from currently limited samples. In addition, the data from our current study and recently published NGS data provide the basis for well-designed gene panels that should include <em>KDM6A/UTX</em> and related histone demethylases for targeted resequencing</p>
<p>We acknowledge the limitations of our study. First, while not all patients had documented progression of disease at study entry, nonetheless, almost all (90%) of the patients did. Second, we did not have a quality of life questionnaire in this trial, which would have helped to capture and describe the clinical improvements observed. Third, we did not have funding to incorporate other imaging modalities, (such as PET/CT), or to utilize other measurement criteria (such as volumetric assessment), which would have helped evaluate the utility of a different imaging criteria in ACC. Fourth, due to the small number of samples analyzed, we could not unequivocally identify mutations that were predictors of response or resistance to vorinostat.</p>
<p>In conclusion, the findings from this study are encouraging. Vorinostat was relatively well tolerated and patients remained on drug treatment for significant periods of time. The clinical benefit rate (97%) was very high, as was the 6-month stable disease rate (75%). Despite a small number of PRs overall, these responses were durable and associated with improvement in symptoms. We found mutations in chromatin remodeling genes in most samples analyzed. Perhaps the fact that ACC has a low rate of somatic mutations, coupled with the pleotropic effects of vorinostat as a modulator of epigenetics, can partly explain this drug's antitumor activity in this disease. In the future, it will be important to assess responses to vorinostat and other HDACi in patients with ACC relative to aberrant epigenetic regulation with tumor gene sequencing. In summary, despite this being a statistically negative trial, we observed clinical improvement in symptoms in several patients, along with two partial responses and a significant decrease in ascites in another patient. We find this study encouraging and will pursue further prospective clinical trials evaluating HDAC inhibitors perhaps in combination with other agents, for the treatment of ACC we find this study encouraging and will pursue further prospective clinical trials evaluating HDAC inhibitors perhaps in combination with other agents, for the treatment of ACC. Such future trials should include additional tumor measurement criteria, such as volumetric tumor measurement and quality of life questionnaires, along with systematic molecular analysis and tumor sequencing.</p></section><section id="s4"><h2 class="pmc_sec_title">MATERIALS AND METHODS</h2>
<section id="s4_1"><h3 class="pmc_sec_title">Eligibility criteria</h3>
<p>Key eligibility criteria included: histologically or cytologically confirmed locally advanced, recurrent or metastatic ACC; age ≥ 18 years; measurable disease per RECIST v1.1; Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2; life expectancy ≥ 12 weeks. Any number of prior chemotherapy regimens was allowed but not required. Laboratory parameters included adequate organ and marrow function defined as: leucocytes ≥ 3,000/μL, absolute neutrophil count ≥ 1,500/μL, platelets ≥ 100,000/μL, total bilirubin within institutional normal limits (WNL), liver enzymes ≤ 2.5X upper limit of normal, and creatinine WNL, or creatinine clearance ≥ 60 mL/min. Patients with previous brain metastases were eligible if they were treated and stable for ≥ 1 month with no requirement for steroids. All patients provided informed consent before treatment. The study complied with local institutional review board guidelines. Baseline formalin fixed paraffin embedded FFPE slides or blocks needed to be available for correlative studies.</p></section><section id="s4_2"><h3 class="pmc_sec_title">Study design and treatment</h3>
<p>This was a multicenter, international, single-arm, phase 2 study. Patients received oral vorinostat 400 mg once a day continuously until disease progression, death, withdrawal of consent, or unacceptable adverse events. Each cycle was defined as 28 days. Imaging was obtained at baseline and repeated every 8 weeks for the first 6 cycles. After 6 months on study, imaging was extended to every 12 weeks. Study visits occurred every 2 weeks for the first 2 cycles, then every 4 weeks thereafter. Safety assessments included physical examinations, AE assessment, and laboratory measurements. AEs were graded according to the Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. Vorinostat was distributed by Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute under a collaborative agreement with Merck &amp; Co. Inc.</p></section><section id="s4_3"><h3 class="pmc_sec_title">Objectives and endpoints</h3>
<p>The primary objective was to evaluate the efficacy as defined by response rate (RR) of vorinostat in patients with ACC. Secondary objectives were to evaluate time to tumor response, response duration (RD), stable disease duration, progression free survival, overall survival and to characterize safety and tolerability of vorinostat in ACC patients. For RD, SDD, and PFS, if progression had not occurred, then their duration was censored as of the date of the most recent tumor assessment. For patients still alive, their OS duration was censored as of the most recent date that the patients’ vital status had been confirmed.</p></section><section id="s4_4"><h3 class="pmc_sec_title">Statistical methods</h3>
<section id="s4_4_1"><h4 class="pmc_sec_title">Design</h4>
<p>Complete + partial (CR+PR) rate was the primary statistical endpoint. We used a 2-stage Simon optimal design with p<sub>0</sub> = 5%, p<sub>1</sub> = 20%, alpha = 0.15, power = 0.90, and PET = 0.540. Stage 1 required 12 patients. At least 1 responder in Stage 1 would be needed to justify continuing to Stage 2, which would require 17 more patients. If &lt; 3 responders, we would conclude that vorinostat has insufficient efficacy to justify further study.</p></section><section id="s4_4_2"><h4 class="pmc_sec_title">Analysis</h4>
<p>95% confidence interval (CI) estimates were calculated via Wilson's method. TTE endpoints were estimated using the Kaplan-Meier (K-M) method. Due to the small numbers of events, point estimates of survival statistics were estimated more conservatively using linear interpolation among successive event times on the K-M curves, and a slightly lower confidence level (90%) was used when determining CI’s. A waterfall plot was used to display the degree of response (percent change in tumor burden).</p></section></section><section id="s4_5"><h3 class="pmc_sec_title">Exploratory studies methods</h3>
<section id="s4_5_1"><h4 class="pmc_sec_title">Whole exome sequencing</h4>
<p>The DNA from FFPE tumor tissue and from normal lymphocytes were extracted with QIAamp<sup>®</sup> FFPE Tissue Kit and QIAamp<sup>®</sup> DNA Blood Mini Kit respectively according to the supplier's instructions. All double strand DNAs were quantified using a QuBit<sup>®</sup> fluorometer. In order to evaluate the clinical samples from the patients with differential responses to vorinostat WES of 5 available tumor normal pairs with sufficient tumor DNA (patients 001–002, 001–004, 001–006, 003–014, 003–027) from the FFPE tissue samples was done using Agilent_V5_PlusUTR_hs37d5_Baits. The sequencing was done through the TGen Collaborative Sequencing Center (for patients 001–004 and 001–006) and the Mayo Clinic Medical Genome Facility (MGF) at a mean depth of 60x coverage according to established protocols [<a href="#R52" class="usa-link" aria-describedby="R52">52</a>]. Observed variants were filtered based on a series of criteria including NextProt Feature Strength, Maximum Population Allele Frequency, and inclusion in the Catalogue of Somatic Mutations in Cancer (COSMIC) database [<a href="#R7" class="usa-link" aria-describedby="R7">7</a>]. The goal was to prioritize those variants that likely disrupt protein function, identify mutations targeting known cancer related genes and pathways, and filter out polymorphisms detected in patient matched normal samples and reported in dbSNP and other population based studies. Of significant interest were those somatic variants that introduced non-synonymous variants within well-annotated cancer associated genes.</p></section><section id="s4_5_2"><h4 class="pmc_sec_title">Targeted resequencing</h4>
<p>In addition to WES, we developed a 10 gene panel to validate mutations and to screen samples with sub optimal levels of DNA for this study. We selected 4 genes from our initial WES results for patients 001–004 and 001–006, and 6 additional genes from previously published ACC data for our 10 gene panel [<a href="#R5" class="usa-link" aria-describedby="R5">5</a>, <a href="#R6" class="usa-link" aria-describedby="R6">6</a>]. Candidate driver aberrations targeting chromatin remodeling (<em>SMARCA2</em>, <em>KDM6A</em>, <em>CREBBP</em>), DNA repair and checkpoints (<em>TP53</em>, <em>MLF1</em>) and cell signaling (<em>PIK3CA</em>, <em>SH2D4A</em>, <em>FZD10</em>) were prioritized based on their biological functions and potential clinical utility. The final 10-gene ACC panel consisted of <em>SH2D4A, FZD10, TP53, PIK3CA, PTEN, SMARCA2, KDM6A, CREBBP, MLF1</em>, and <em>N4BP2</em>. Primers were designed for each of the 10 genes with coverage for all exons and untranslated sequencings (UTRs) using the Ion Ampliseq<sup>TM</sup> Designer <a href="https://www.ampliseq.com/browse.action" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ampliseq.com/browse.action</a>. Our targeted resequencing 10 gene FFPE specific input panel has 87.65% coverage with 644 amplicons ranging from 125–175 base pairs in length, for a total of 62.09 kb of sequence. This design provides validation of the 4 novel mutations identified in the initial whole exome data and increases the probability of identifying additional mutations that converge on each of the 10 genes in the panel. For exploratory purposes, patients were qualified as either “responders” (7/11 patients) or “non-responders” (4/11 patients) based on whether they had a PR by RECIST (<em>n</em> = 2), prolonged SD, clinical benefit to vorinostat or progressed quickly on study. To investigate the role of somatic mutations in responses to vorinostat we assembled archival FFPE blocks from 2 patients and FFPE slides from an additional 9 patients treated with vorinostat. We obtained patient matched normal blood samples as controls. In total we screened both tumor and normal tissues from each of 8 patients (from 6 “responders” and 2 “non-responders”), including the 5 cases that were analyzed by WES with this panel using the Ion Torrent platform. In the remaining 3 cases there was insufficient material for either WES or target resequencing. A full description of the methods can be found in the Supplementary File.</p></section></section></section><section id="s5"><h2 class="pmc_sec_title">SUPPLEMENTARY MATERIALS TABLE AND FIGURES</h2>
<section class="sm xbox font-sm" id="SD1"><div class="media p" id="d35e1829"><div class="caption">
<a href="/articles/instance/5464838/bin/oncotarget-08-32918-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">oncotarget-08-32918-s001.pdf</a><sup> (1.6MB, pdf) </sup>
</div></div></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Authors’ contributions</strong></p>
<p>Conception and design of work: PG, LH, MB, RP, PL. Data Collection: PG, SK, AH, LS, AS, JC, MP, LC, AC, PL. Data analysis and interpretation: PG, LH, MB, DS, EL, SM, PL. Drafting the article: PG, LH, MB, PL, DS. Critical revision of the article: All authors. Final approval of the version to be published: All authors.</p>
</div>
<div class="fn p" id="fn2">
<p><strong>CONFLICTS OF INTEREST</strong></p>
<p>All authors except LS and JC have no conflicts of interest. LS has research funding (for clinical trials) from Merck and is on Merck advisory board. JC has research funding (institutional for clinical trials) from Merck.</p>
</div>
<div class="fn p" id="fn3">
<p><strong>FUNDING</strong></p>
<p>Supported by 5U01CA062487/19 and U01 grant (5U01CA132123). Partially funded by the Adenoid Cystic Carcinoma Research Foundation (ACCRF) and by NIH Cancer Center Support Grant CA-22453.</p>
</div>
</div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>Ellington CL, Goodman M, Kono SA, Grist W, Wadsworth T, Chen AY, Owonikoko T, Ramalingam S, Shin DM, Khuri FR, Beitler JJ, Saba NF. Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973–2007 Surveillance, Epidemiology, and End Results data. Cancer. 2012;118:4444–4451. doi: 10.1002/cncr.27408.</cite> [<a href="https://doi.org/10.1002/cncr.27408" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22294420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Adenoid%20cystic%20carcinoma%20of%20the%20head%20and%20neck:%20Incidence%20and%20survival%20trends%20based%20on%201973%E2%80%932007%20Surveillance,%20Epidemiology,%20and%20End%20Results%20data&amp;author=CL%20Ellington&amp;author=M%20Goodman&amp;author=SA%20Kono&amp;author=W%20Grist&amp;author=T%20Wadsworth&amp;volume=118&amp;publication_year=2012&amp;pages=4444-4451&amp;pmid=22294420&amp;doi=10.1002/cncr.27408&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R2">
<span class="label">2.</span><cite>Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. American journal of surgery. 1997;174:495–498. doi: 10.1016/s0002-9610(97)00153-0.</cite> [<a href="https://doi.org/10.1016/s0002-9610(97)00153-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9374223/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20journal%20of%20surgery&amp;title=Distant%20metastasis%20in%20adenoid%20cystic%20carcinoma%20of%20salivary%20origin&amp;author=RH%20Spiro&amp;volume=174&amp;publication_year=1997&amp;pages=495-498&amp;pmid=9374223&amp;doi=10.1016/s0002-9610(97)00153-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>Chae YK, Chung SY, Davis AA, Carneiro BA, Chandra S, Kaplan J, Kalyan A, Giles FJ. Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling. Oncotarget. 2015;6:37117–37134. doi: 10.18632/oncotarget.5076.</cite> [<a href="https://doi.org/10.18632/oncotarget.5076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4741919/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26359351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Adenoid%20cystic%20carcinoma:%20current%20therapy%20and%20potential%20therapeutic%20advances%20based%20on%20genomic%20profiling&amp;author=YK%20Chae&amp;author=SY%20Chung&amp;author=AA%20Davis&amp;author=BA%20Carneiro&amp;author=S%20Chandra&amp;volume=6&amp;publication_year=2015&amp;pages=37117-37134&amp;pmid=26359351&amp;doi=10.18632/oncotarget.5076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>Ramalingam SS, Kummar S, Sarantopoulos J, Shibata S, LoRusso P, Yerk M, Holleran J, Lin Y, Beumer JH, Harvey RD, Ivy SP, Belani CP, Egorin MJ. Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study. J Clin Oncol. 2010;28:4507–4512. doi: 10.1200/JCO.2010.30.2307.</cite> [<a href="https://doi.org/10.1200/JCO.2010.30.2307" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2988640/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20837947/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Phase%20I%20study%20of%20vorinostat%20in%20patients%20with%20advanced%20solid%20tumors%20and%20hepatic%20dysfunction:%20a%20National%20Cancer%20Institute%20Organ%20Dysfunction%20Working%20Group%20study&amp;author=SS%20Ramalingam&amp;author=S%20Kummar&amp;author=J%20Sarantopoulos&amp;author=S%20Shibata&amp;author=P%20LoRusso&amp;volume=28&amp;publication_year=2010&amp;pages=4507-4512&amp;pmid=20837947&amp;doi=10.1200/JCO.2010.30.2307&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Stephens PJ, Davies HR, Mitani Y, Van Loo P, Shlien A, Tarpey PS, Papaemmanuil E, Cheverton A, Bignell GR, Butler AP, Gamble J, Gamble S, Hardy C, et al.  Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest. 2013;123:2965–2968. doi: 10.1172/JCI67201.</cite> [<a href="https://doi.org/10.1172/JCI67201" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3999050/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23778141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Invest&amp;title=Whole%20exome%20sequencing%20of%20adenoid%20cystic%20carcinoma&amp;author=PJ%20Stephens&amp;author=HR%20Davies&amp;author=Y%20Mitani&amp;author=P%20Van%20Loo&amp;author=A%20Shlien&amp;volume=123&amp;publication_year=2013&amp;pages=2965-2968&amp;pmid=23778141&amp;doi=10.1172/JCI67201&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, Ramaswami D, Walsh LA, Eng S, Huse JT, Zhang J, Dolgalev I, Huberman K, et al.  The mutational landscape of adenoid cystic carcinoma. Nat Genet. 2013;45:791–798. doi: 10.1038/ng.2643.</cite> [<a href="https://doi.org/10.1038/ng.2643" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3708595/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23685749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=The%20mutational%20landscape%20of%20adenoid%20cystic%20carcinoma&amp;author=AS%20Ho&amp;author=K%20Kannan&amp;author=DM%20Roy&amp;author=LG%20Morris&amp;author=I%20Ganly&amp;volume=45&amp;publication_year=2013&amp;pages=791-798&amp;pmid=23685749&amp;doi=10.1038/ng.2643&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, Ding M, Bamford S, Cole C, Ward S, Kok CY, Jia M, De T, et al.  COSMIC: exploring the world’s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 2015;43:D805–811. doi: 10.1093/nar/gku1075.</cite> [<a href="https://doi.org/10.1093/nar/gku1075" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4383913/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25355519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=COSMIC:%20exploring%20the%20world%E2%80%99s%20knowledge%20of%20somatic%20mutations%20in%20human%20cancer&amp;author=SA%20Forbes&amp;author=D%20Beare&amp;author=P%20Gunasekaran&amp;author=K%20Leung&amp;author=N%20Bindal&amp;volume=43&amp;publication_year=2015&amp;pages=D805-811&amp;pmid=25355519&amp;doi=10.1093/nar/gku1075&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>Yoneda-Kato N, Tomoda K, Umehara M, Arata Y, Kato JY. Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3. EMBO J. 2005;24:1739–1749. doi: 10.1038/sj.emboj.7600656.</cite> [<a href="https://doi.org/10.1038/sj.emboj.7600656" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1142586/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15861129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EMBO%20J&amp;title=Myeloid%20leukemia%20factor%201%20regulates%20p53%20by%20suppressing%20COP1%20via%20COP9%20signalosome%20subunit%203&amp;author=N%20Yoneda-Kato&amp;author=K%20Tomoda&amp;author=M%20Umehara&amp;author=Y%20Arata&amp;author=JY%20Kato&amp;volume=24&amp;publication_year=2005&amp;pages=1739-1749&amp;pmid=15861129&amp;doi=10.1038/sj.emboj.7600656&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Watanabe N, Wachi S, Fujita T. Identification and characterization of BCL-3-binding protein: implications for transcription and DNA repair or recombination. J Biol Chem. 2003;278:26102–26110. doi: 10.1074/jbc.M303518200.</cite> [<a href="https://doi.org/10.1074/jbc.M303518200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12730195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&amp;title=Identification%20and%20characterization%20of%20BCL-3-binding%20protein:%20implications%20for%20transcription%20and%20DNA%20repair%20or%20recombination&amp;author=N%20Watanabe&amp;author=S%20Wachi&amp;author=T%20Fujita&amp;volume=278&amp;publication_year=2003&amp;pages=26102-26110&amp;pmid=12730195&amp;doi=10.1074/jbc.M303518200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Wang K, Kan J, Yuen ST, Shi ST, Chu KM, Law S, Chan TL, Kan Z, Chan AS, Tsui WY, Lee SP, Ho SL, Chan AK, et al.  Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet. 2011;43:1219–1223. doi: 10.1038/ng.982.</cite> [<a href="https://doi.org/10.1038/ng.982" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22037554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=Exome%20sequencing%20identifies%20frequent%20mutation%20of%20ARID1A%20in%20molecular%20subtypes%20of%20gastric%20cancer&amp;author=K%20Wang&amp;author=J%20Kan&amp;author=ST%20Yuen&amp;author=ST%20Shi&amp;author=KM%20Chu&amp;volume=43&amp;publication_year=2011&amp;pages=1219-1223&amp;pmid=22037554&amp;doi=10.1038/ng.982&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–337. doi: 10.1038/nature11252.</cite> [<a href="https://doi.org/10.1038/nature11252" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3401966/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22810696/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Comprehensive%20molecular%20characterization%20of%20human%20colon%20and%20rectal%20cancer&amp;author=N%20Cancer%20Genome%20Atlas&amp;volume=487&amp;publication_year=2012&amp;pages=330-337&amp;pmid=22810696&amp;doi=10.1038/nature11252&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Li T, Li W, Lu J, Liu H, Li Y, Zhao Y. SH2D4A regulates cell proliferation via the ERalpha/PLC-gamma/PKC pathway. BMB Rep. 2009;42:516–522. doi: 10.5483/bmbrep.2009.42.8.516.</cite> [<a href="https://doi.org/10.5483/bmbrep.2009.42.8.516" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19712589/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMB%20Rep&amp;title=SH2D4A%20regulates%20cell%20proliferation%20via%20the%20ERalpha/PLC-gamma/PKC%20pathway&amp;author=T%20Li&amp;author=W%20Li&amp;author=J%20Lu&amp;author=H%20Liu&amp;author=Y%20Li&amp;volume=42&amp;publication_year=2009&amp;pages=516-522&amp;pmid=19712589&amp;doi=10.5483/bmbrep.2009.42.8.516&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Koike J, Takagi A, Miwa T, Hirai M, Terada M, Katoh M. Molecular cloning of Frizzled-10, a novel member of the Frizzled gene family. Biochem Biophys Res Commun. 1999;262:39–43. doi: 10.1006/bbrc.1999.1161.</cite> [<a href="https://doi.org/10.1006/bbrc.1999.1161" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10448064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20Biophys%20Res%20Commun&amp;title=Molecular%20cloning%20of%20Frizzled-10,%20a%20novel%20member%20of%20the%20Frizzled%20gene%20family&amp;author=J%20Koike&amp;author=A%20Takagi&amp;author=T%20Miwa&amp;author=M%20Hirai&amp;author=M%20Terada&amp;volume=262&amp;publication_year=1999&amp;pages=39-43&amp;pmid=10448064&amp;doi=10.1006/bbrc.1999.1161&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Cao R, Wang H, He J, Erdjument-Bromage H, Tempst P, Zhang Y. Role of hPHF1 in H3K27 methylation and Hox gene silencing. Mol Cell Biol. 2008;28:1862–1872. doi: 10.1128/MCB.01589-07.</cite> [<a href="https://doi.org/10.1128/MCB.01589-07" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2258785/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18086877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell%20Biol&amp;title=Role%20of%20hPHF1%20in%20H3K27%20methylation%20and%20Hox%20gene%20silencing&amp;author=R%20Cao&amp;author=H%20Wang&amp;author=J%20He&amp;author=H%20Erdjument-Bromage&amp;author=P%20Tempst&amp;volume=28&amp;publication_year=2008&amp;pages=1862-1872&amp;pmid=18086877&amp;doi=10.1128/MCB.01589-07&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R15">
<span class="label">15.</span><cite>Yang Y, Wang C, Zhang P, Gao K, Wang D, Yu H, Zhang T, Jiang S, Hexige S, Hong Z, Yasui A, Liu JO, Huang H, et al.  Polycomb group protein PHF1 regulates p53-dependent cell growth arrest and apoptosis. J Biol Chem. 2013;288:529–539. doi: 10.1074/jbc.M111.338996.</cite> [<a href="https://doi.org/10.1074/jbc.M111.338996" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3537050/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23150668/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&amp;title=Polycomb%20group%20protein%20PHF1%20regulates%20p53-dependent%20cell%20growth%20arrest%20and%20apoptosis&amp;author=Y%20Yang&amp;author=C%20Wang&amp;author=P%20Zhang&amp;author=K%20Gao&amp;author=D%20Wang&amp;volume=288&amp;publication_year=2013&amp;pages=529-539&amp;pmid=23150668&amp;doi=10.1074/jbc.M111.338996&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R16">
<span class="label">16.</span><cite>Hong Z, Jiang J, Lan L, Nakajima S, Kanno S, Koseki H, Yasui A. A polycomb group protein, PHF1, is involved in the response to DNA double-strand breaks in human cell. Nucleic Acids Res. 2008;36:2939–2947. doi: 10.1093/nar/gkn146.</cite> [<a href="https://doi.org/10.1093/nar/gkn146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2396414/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18385154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=A%20polycomb%20group%20protein,%20PHF1,%20is%20involved%20in%20the%20response%20to%20DNA%20double-strand%20breaks%20in%20human%20cell&amp;author=Z%20Hong&amp;author=J%20Jiang&amp;author=L%20Lan&amp;author=S%20Nakajima&amp;author=S%20Kanno&amp;volume=36&amp;publication_year=2008&amp;pages=2939-2947&amp;pmid=18385154&amp;doi=10.1093/nar/gkn146&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Micci F, Panagopoulos I, Bjerkehagen B, Heim S. Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. Cancer Res. 2006;66:107–112. doi: 10.1158/0008-5472.CAN-05-2485.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-05-2485" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16397222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Consistent%20rearrangement%20of%20chromosomal%20band%206p21%20with%20generation%20of%20fusion%20genes%20JAZF1/PHF1%20and%20EPC1/PHF1%20in%20endometrial%20stromal%20sarcoma&amp;author=F%20Micci&amp;author=I%20Panagopoulos&amp;author=B%20Bjerkehagen&amp;author=S%20Heim&amp;volume=66&amp;publication_year=2006&amp;pages=107-112&amp;pmid=16397222&amp;doi=10.1158/0008-5472.CAN-05-2485&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R18">
<span class="label">18.</span><cite>Panagopoulos I, Micci F, Thorsen J, Gorunova L, Eibak AM, Bjerkehagen B, Davidson B, Heim S. Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma. PLoS One. 2012;7:e39354. doi: 10.1371/journal.pone.0039354.</cite> [<a href="https://doi.org/10.1371/journal.pone.0039354" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3382230/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22761769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Novel%20fusion%20of%20MYST/Esa1-associated%20factor%206%20and%20PHF1%20in%20endometrial%20stromal%20sarcoma&amp;author=I%20Panagopoulos&amp;author=F%20Micci&amp;author=J%20Thorsen&amp;author=L%20Gorunova&amp;author=AM%20Eibak&amp;volume=7&amp;publication_year=2012&amp;pages=e39354&amp;pmid=22761769&amp;doi=10.1371/journal.pone.0039354&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Chen S, Evans HG, Evans DR. FAM129B/MINERVA, a novel adherens junction-associated protein, suppresses apoptosis in HeLa cells. J Biol Chem. 2011;286:10201–10209. doi: 10.1074/jbc.M110.175273.</cite> [<a href="https://doi.org/10.1074/jbc.M110.175273" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3060473/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21148485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&amp;title=FAM129B/MINERVA,%20a%20novel%20adherens%20junction-associated%20protein,%20suppresses%20apoptosis%20in%20HeLa%20cells&amp;author=S%20Chen&amp;author=HG%20Evans&amp;author=DR%20Evans&amp;volume=286&amp;publication_year=2011&amp;pages=10201-10209&amp;pmid=21148485&amp;doi=10.1074/jbc.M110.175273&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R20">
<span class="label">20.</span><cite>Drier Y, Cotton MJ, Williamson KE, Gillespie SM, Ryan RJ, Kluk MJ, Carey CD, Rodig SJ, Sholl LM, Afrogheh AH, Faquin WC, Queimado L, Qi J, et al.  An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet. 2016;48:265–272. doi: 10.1038/ng.3502.</cite> [<a href="https://doi.org/10.1038/ng.3502" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4767593/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26829750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=An%20oncogenic%20MYB%20feedback%20loop%20drives%20alternate%20cell%20fates%20in%20adenoid%20cystic%20carcinoma&amp;author=Y%20Drier&amp;author=MJ%20Cotton&amp;author=KE%20Williamson&amp;author=SM%20Gillespie&amp;author=RJ%20Ryan&amp;volume=48&amp;publication_year=2016&amp;pages=265-272&amp;pmid=26829750&amp;doi=10.1038/ng.3502&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Malecki MJ, Sanchez-Irizarry C, Mitchell JL, Histen G, Xu ML, Aster JC, Blacklow SC. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes. Mol Cell Biol. 2006;26:4642–4651. doi: 10.1128/MCB.01655-05.</cite> [<a href="https://doi.org/10.1128/MCB.01655-05" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1489116/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16738328/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell%20Biol&amp;title=Leukemia-associated%20mutations%20within%20the%20NOTCH1%20heterodimerization%20domain%20fall%20into%20at%20least%20two%20distinct%20mechanistic%20classes&amp;author=MJ%20Malecki&amp;author=C%20Sanchez-Irizarry&amp;author=JL%20Mitchell&amp;author=G%20Histen&amp;author=ML%20Xu&amp;volume=26&amp;publication_year=2006&amp;pages=4642-4651&amp;pmid=16738328&amp;doi=10.1128/MCB.01655-05&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Wang NJ, Sanborn Z, Arnett KL, Bayston LJ, Liao W, Proby CM, Leigh IM, Collisson EA, Gordon PB, Jakkula L, Pennypacker S, Zou Y, Sharma M, et al.  Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proced Natl Acad Sci USA. 2011;108:17761–17766. doi: 10.1073/pnas.1114669108.</cite> [<a href="https://doi.org/10.1073/pnas.1114669108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3203814/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22006338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proced%20Natl%20Acad%20Sci%20USA&amp;title=Loss-of-function%20mutations%20in%20Notch%20receptors%20in%20cutaneous%20and%20lung%20squamous%20cell%20carcinoma&amp;author=NJ%20Wang&amp;author=Z%20Sanborn&amp;author=KL%20Arnett&amp;author=LJ%20Bayston&amp;author=W%20Liao&amp;volume=108&amp;publication_year=2011&amp;pages=17761-17766&amp;pmid=22006338&amp;doi=10.1073/pnas.1114669108&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C, Edkins S, Hardy C, O’Meara S, Teague J, Butler A, Hinton J, Latimer C, et al.  Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet. 2009;41:521–523. doi: 10.1038/ng.349.</cite> [<a href="https://doi.org/10.1038/ng.349" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2873835/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19330029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=Somatic%20mutations%20of%20the%20histone%20H3K27%20demethylase%20gene%20UTX%20in%20human%20cancer&amp;author=G%20van%20Haaften&amp;author=GL%20Dalgliesh&amp;author=H%20Davies&amp;author=L%20Chen&amp;author=G%20Bignell&amp;volume=41&amp;publication_year=2009&amp;pages=521-523&amp;pmid=19330029&amp;doi=10.1038/ng.349&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Sanghvi S, Patel NR, Patel CR, Kalyoussef E, Baredes S, Eloy JA. Sinonasal adenoid cystic carcinoma: comprehensive analysis of incidence and survival from 1973 to 2009. Laryngoscope. 2013;123:1592–1597. doi: 10.1002/lary.24085.</cite> [<a href="https://doi.org/10.1002/lary.24085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23553267/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Laryngoscope&amp;title=Sinonasal%20adenoid%20cystic%20carcinoma:%20comprehensive%20analysis%20of%20incidence%20and%20survival%20from%201973%20to%202009&amp;author=S%20Sanghvi&amp;author=NR%20Patel&amp;author=CR%20Patel&amp;author=E%20Kalyoussef&amp;author=S%20Baredes&amp;volume=123&amp;publication_year=2013&amp;pages=1592-1597&amp;pmid=23553267&amp;doi=10.1002/lary.24085&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>Hotte SJ, Winquist EW, Lamont E, MacKenzie M, Vokes E, Chen EX, Brown S, Pond GR, Murgo A, Siu LL. Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol. 2005;23:585–590. doi: 10.1200/JCO.2005.06.125.</cite> [<a href="https://doi.org/10.1200/JCO.2005.06.125" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15659505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Imatinib%20mesylate%20in%20patients%20with%20adenoid%20cystic%20cancers%20of%20the%20salivary%20glands%20expressing%20c-kit:%20a%20Princess%20Margaret%20Hospital%20phase%20II%20consortium%20study&amp;author=SJ%20Hotte&amp;author=EW%20Winquist&amp;author=E%20Lamont&amp;author=M%20MacKenzie&amp;author=E%20Vokes&amp;volume=23&amp;publication_year=2005&amp;pages=585-590&amp;pmid=15659505&amp;doi=10.1200/JCO.2005.06.125&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R26">
<span class="label">26.</span><cite>Agulnik M, Cohen EW, Cohen RB, Chen EX, Vokes EE, Hotte SJ, Winquist E, Laurie S, Hayes DN, Dancey JE, Brown S, Pond GR, Lorimer I, et al.  Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. J Clin Oncol. 2007;25:3978–3984. doi: 10.1200/JCO.2007.11.8612.</cite> [<a href="https://doi.org/10.1200/JCO.2007.11.8612" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17761983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Phase%20II%20study%20of%20lapatinib%20in%20recurrent%20or%20metastatic%20epidermal%20growth%20factor%20receptor%20and/or%20erbB2%20expressing%20adenoid%20cystic%20carcinoma%20and%20non%20adenoid%20cystic%20carcinoma%20malignant%20tumors%20of%20the%20salivary%20glands&amp;author=M%20Agulnik&amp;author=EW%20Cohen&amp;author=RB%20Cohen&amp;author=EX%20Chen&amp;author=EE%20Vokes&amp;volume=25&amp;publication_year=2007&amp;pages=3978-3984&amp;pmid=17761983&amp;doi=10.1200/JCO.2007.11.8612&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>Thomson DJ, Silva P, Denton K, Bonington S, Mak SK, Swindell R, Homer J, Sykes AJ, Lee LW, Yap BK, Slevin NJ. Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck. Head Neck. 2015;37:182–187. doi: 10.1002/hed.23577.</cite> [<a href="https://doi.org/10.1002/hed.23577" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24346857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Head%20Neck&amp;title=Phase%20II%20trial%20of%20sorafenib%20in%20advanced%20salivary%20adenoid%20cystic%20carcinoma%20of%20the%20head%20and%20neck&amp;author=DJ%20Thomson&amp;author=P%20Silva&amp;author=K%20Denton&amp;author=S%20Bonington&amp;author=SK%20Mak&amp;volume=37&amp;publication_year=2015&amp;pages=182-187&amp;pmid=24346857&amp;doi=10.1002/hed.23577&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Wong SJ, Karrison T, Hayes DN, Kies MS, Cullen KJ, Tanvetyanon T, Argiris A, Takebe N, Lim D, Saba NF, Worden FP, Gilbert J, Lenz HJ, et al.  Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Ann Oncol. 2016;27:318–323. doi: 10.1093/annonc/mdv537.</cite> [<a href="https://doi.org/10.1093/annonc/mdv537" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4722891/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26598548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=Phase%20II%20trial%20of%20dasatinib%20for%20recurrent%20or%20metastatic%20c-KIT%20expressing%20adenoid%20cystic%20carcinoma%20and%20for%20nonadenoid%20cystic%20malignant%20salivary%20tumors&amp;author=SJ%20Wong&amp;author=T%20Karrison&amp;author=DN%20Hayes&amp;author=MS%20Kies&amp;author=KJ%20Cullen&amp;volume=27&amp;publication_year=2016&amp;pages=318-323&amp;pmid=26598548&amp;doi=10.1093/annonc/mdv537&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>Dillon PM, Petroni GR, Horton BJ, Moskaluk CA, Fracasso PM, Douvas MG, Varhegyi N, Zaja-Milatovic S, Thomas CY. A Phase II study of Dovitinib in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma. Clin Cancer Res. Apr 4; doi: 10.1158/1078-0432.CCR-16-2942. [Epub ahead of print]</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-16-2942" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5540767/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28377480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=A%20Phase%20II%20study%20of%20Dovitinib%20in%20Patients%20With%20Recurrent%20or%20Metastatic%20Adenoid%20Cystic%20Carcinoma&amp;author=PM%20Dillon&amp;author=GR%20Petroni&amp;author=BJ%20Horton&amp;author=CA%20Moskaluk&amp;author=PM%20Fracasso&amp;pmid=28377480&amp;doi=10.1158/1078-0432.CCR-16-2942&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Keam B, Kim SB, Shin SH, Cho BC, Lee KW, Kim MK, Yun HJ, Lee SH, Yoon DH, Bang YJ. Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma. Cancer. 2015;121:2612–2617. doi: 10.1002/cncr.29401.</cite> [<a href="https://doi.org/10.1002/cncr.29401" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25903089/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Phase%202%20study%20of%20dovitinib%20in%20patients%20with%20metastatic%20or%20unresectable%20adenoid%20cystic%20carcinoma&amp;author=B%20Keam&amp;author=SB%20Kim&amp;author=SH%20Shin&amp;author=BC%20Cho&amp;author=KW%20Lee&amp;volume=121&amp;publication_year=2015&amp;pages=2612-2617&amp;pmid=25903089&amp;doi=10.1002/cncr.29401&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Ho AL, Dunn L, Sherman EJ, Fury MG, Baxi SS, Chandramohan R, Dogan S, Morris LG, Cullen GD, Haque S, Sima CS, Ni A, Antonescu CR, et al.  A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma. Ann Oncol. 2016;27:1902–1908. doi: 10.1093/annonc/mdw287.</cite> [<a href="https://doi.org/10.1093/annonc/mdw287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5035791/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27566443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=A%20phase%20II%20study%20of%20axitinib%20(AG-013736)%20in%20patients%20with%20incurable%20adenoid%20cystic%20carcinoma&amp;author=AL%20Ho&amp;author=L%20Dunn&amp;author=EJ%20Sherman&amp;author=MG%20Fury&amp;author=SS%20Baxi&amp;volume=27&amp;publication_year=2016&amp;pages=1902-1908&amp;pmid=27566443&amp;doi=10.1093/annonc/mdw287&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>Laurie SA, Ho AL, Fury MG, Sherman E, Pfister DG. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Lancet Oncol. 2011;12:815–824. doi: 10.1016/S1470-2045(10)70245-X.</cite> [<a href="https://doi.org/10.1016/S1470-2045(10)70245-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21147032/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Systemic%20therapy%20in%20the%20management%20of%20metastatic%20or%20locally%20recurrent%20adenoid%20cystic%20carcinoma%20of%20the%20salivary%20glands:%20a%20systematic%20review&amp;author=SA%20Laurie&amp;author=AL%20Ho&amp;author=MG%20Fury&amp;author=E%20Sherman&amp;author=DG%20Pfister&amp;volume=12&amp;publication_year=2011&amp;pages=815-824&amp;pmid=21147032&amp;doi=10.1016/S1470-2045(10)70245-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R33">
<span class="label">33.</span><cite>Locati LD, Perrone F, Cortelazzi B, Bergamini C, Bossi P, Civelli E, Morosi C, Lo Vullo S, Imbimbo M, Quattrone P, Dagrada GP, Granata R, Resteghini C, et al.  A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact. Eur J Cancer. 2016;69:158–165. doi: 10.1016/j.ejca.2016.09.022.</cite> [<a href="https://doi.org/10.1016/j.ejca.2016.09.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27821319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Cancer&amp;title=A%20phase%20II%20study%20of%20sorafenib%20in%20recurrent%20and/or%20metastatic%20salivary%20gland%20carcinomas:%20Translational%20analyses%20and%20clinical%20impact&amp;author=LD%20Locati&amp;author=F%20Perrone&amp;author=B%20Cortelazzi&amp;author=C%20Bergamini&amp;author=P%20Bossi&amp;volume=69&amp;publication_year=2016&amp;pages=158-165&amp;pmid=27821319&amp;doi=10.1016/j.ejca.2016.09.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer. 2009;45:228–247. doi: 10.1016/j.ejca.2008.10.026.</cite> [<a href="https://doi.org/10.1016/j.ejca.2008.10.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19097774/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Cancer&amp;title=New%20response%20evaluation%20criteria%20in%20solid%20tumours:%20revised%20RECIST%20guideline%20(version%201.1)&amp;author=EA%20Eisenhauer&amp;author=P%20Therasse&amp;author=J%20Bogaerts&amp;author=LH%20Schwartz&amp;author=D%20Sargent&amp;volume=45&amp;publication_year=2009&amp;pages=228-247&amp;pmid=19097774&amp;doi=10.1016/j.ejca.2008.10.026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol. 2007;25:1753–1759. doi: 10.1200/JCO.2006.07.3049.</cite> [<a href="https://doi.org/10.1200/JCO.2006.07.3049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17470865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Correlation%20of%20computed%20tomography%20and%20positron%20emission%20tomography%20in%20patients%20with%20metastatic%20gastrointestinal%20stromal%20tumor%20treated%20at%20a%20single%20institution%20with%20imatinib%20mesylate:%20proposal%20of%20new%20computed%20tomography%20response%20criteria&amp;author=H%20Choi&amp;author=C%20Charnsangavej&amp;author=SC%20Faria&amp;author=HA%20Macapinlac&amp;author=MA%20Burgess&amp;volume=25&amp;publication_year=2007&amp;pages=1753-1759&amp;pmid=17470865&amp;doi=10.1200/JCO.2006.07.3049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R36">
<span class="label">36.</span><cite>Dudeck O, Zeile M, Reichardt P, Pink D. Comparison of RECIST and Choi criteria for computed tomographic response evaluation in patients with advanced gastrointestinal stromal tumor treated with sunitinib. Ann Oncol. 2011;22:1828–1833. doi: 10.1093/annonc/mdq696.</cite> [<a href="https://doi.org/10.1093/annonc/mdq696" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21289369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=Comparison%20of%20RECIST%20and%20Choi%20criteria%20for%20computed%20tomographic%20response%20evaluation%20in%20patients%20with%20advanced%20gastrointestinal%20stromal%20tumor%20treated%20with%20sunitinib&amp;author=O%20Dudeck&amp;author=M%20Zeile&amp;author=P%20Reichardt&amp;author=D%20Pink&amp;volume=22&amp;publication_year=2011&amp;pages=1828-1833&amp;pmid=21289369&amp;doi=10.1093/annonc/mdq696&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R37">
<span class="label">37.</span><cite>Wolchok JD, Hoos A, O’Day S, Weber JS, Hamid O, Lebbe C, Maio M, Binder M, Bohnsack O, Nichol G, Humphrey R, Hodi FS. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clini Cancer Res. 2009;15:7412–7420. doi: 10.1158/1078-0432.CCR-09-1624.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-09-1624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19934295/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clini%20Cancer%20Res&amp;title=Guidelines%20for%20the%20evaluation%20of%20immune%20therapy%20activity%20in%20solid%20tumors:%20immune-related%20response%20criteria&amp;author=JD%20Wolchok&amp;author=A%20Hoos&amp;author=S%20O%E2%80%99Day&amp;author=JS%20Weber&amp;author=O%20Hamid&amp;volume=15&amp;publication_year=2009&amp;pages=7412-7420&amp;pmid=19934295&amp;doi=10.1158/1078-0432.CCR-09-1624&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R38">
<span class="label">38.</span><cite>Nishino M, Jagannathan JP, Krajewski KM, O’Regan K, Hatabu H, Shapiro G, Ramaiya NH. Personalized tumor response assessment in the era of molecular medicine: cancer-specific and therapy-specific response criteria to complement pitfalls of RECIST. Am J Roentgenol. 2012;198:737–745. doi: 10.2214/AJR.11.7483.</cite> [<a href="https://doi.org/10.2214/AJR.11.7483" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3369700/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22451534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Roentgenol&amp;title=Personalized%20tumor%20response%20assessment%20in%20the%20era%20of%20molecular%20medicine:%20cancer-specific%20and%20therapy-specific%20response%20criteria%20to%20complement%20pitfalls%20of%20RECIST&amp;author=M%20Nishino&amp;author=JP%20Jagannathan&amp;author=KM%20Krajewski&amp;author=K%20O%E2%80%99Regan&amp;author=H%20Hatabu&amp;volume=198&amp;publication_year=2012&amp;pages=737-745&amp;pmid=22451534&amp;doi=10.2214/AJR.11.7483&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R39">
<span class="label">39.</span><cite>Nishino M, Jackman DM, Hatabu H, Janne PA, Johnson BE, Van den Abbeele AD. Imaging of lung cancer in the era of molecular medicine. Acad Radiol. 2011;18:424–436. doi: 10.1016/j.acra.2010.10.020.</cite> [<a href="https://doi.org/10.1016/j.acra.2010.10.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3380440/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21277232/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acad%20Radiol&amp;title=Imaging%20of%20lung%20cancer%20in%20the%20era%20of%20molecular%20medicine&amp;author=M%20Nishino&amp;author=DM%20Jackman&amp;author=H%20Hatabu&amp;author=PA%20Janne&amp;author=BE%20Johnson&amp;volume=18&amp;publication_year=2011&amp;pages=424-436&amp;pmid=21277232&amp;doi=10.1016/j.acra.2010.10.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R40">
<span class="label">40.</span><cite>Nishino M, Dahlberg SE, Cardarella S, Jackman DM, Rabin MS, Ramaiya NH, Hatabu H, Janne PA, Johnson BE. Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy: developing criteria to continue therapy beyond RECIST progression. Cancer. 2013;119:3761–3768. doi: 10.1002/cncr.28290.</cite> [<a href="https://doi.org/10.1002/cncr.28290" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3817609/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23922022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Volumetric%20tumor%20growth%20in%20advanced%20non-small%20cell%20lung%20cancer%20patients%20with%20EGFR%20mutations%20during%20EGFR-tyrosine%20kinase%20inhibitor%20therapy:%20developing%20criteria%20to%20continue%20therapy%20beyond%20RECIST%20progression&amp;author=M%20Nishino&amp;author=SE%20Dahlberg&amp;author=S%20Cardarella&amp;author=DM%20Jackman&amp;author=MS%20Rabin&amp;volume=119&amp;publication_year=2013&amp;pages=3761-3768&amp;pmid=23922022&amp;doi=10.1002/cncr.28290&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R41">
<span class="label">41.</span><cite>Mozley PD, Schwartz LH, Bendtsen C, Zhao B, Petrick N, Buckler AJ. Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence. Ann Oncol. 2010;21:1751–1755. doi: 10.1093/annonc/mdq051.</cite> [<a href="https://doi.org/10.1093/annonc/mdq051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20332135/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=Change%20in%20lung%20tumor%20volume%20as%20a%20biomarker%20of%20treatment%20response:%20a%20critical%20review%20of%20the%20evidence&amp;author=PD%20Mozley&amp;author=LH%20Schwartz&amp;author=C%20Bendtsen&amp;author=B%20Zhao&amp;author=N%20Petrick&amp;volume=21&amp;publication_year=2010&amp;pages=1751-1755&amp;pmid=20332135&amp;doi=10.1093/annonc/mdq051&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R42">
<span class="label">42.</span><cite>Lipscomb J, Gotay CC, Snyder CF. Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin. 2007;57:278–300. doi: 10.3322/CA.57.5.278.</cite> [<a href="https://doi.org/10.3322/CA.57.5.278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17855485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J%20Clin&amp;title=Patient-reported%20outcomes%20in%20cancer:%20a%20review%20of%20recent%20research%20and%20policy%20initiatives&amp;author=J%20Lipscomb&amp;author=CC%20Gotay&amp;author=CF%20Snyder&amp;volume=57&amp;publication_year=2007&amp;pages=278-300&amp;pmid=17855485&amp;doi=10.3322/CA.57.5.278&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R43">
<span class="label">43.</span><cite>Brogdon JL, Xu Y, Szabo SJ, An S, Buxton F, Cohen D, Huang Q. Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function. Blood. 2007;109:1123–1130. doi: 10.1182/blood-2006-04-019711.</cite> [<a href="https://doi.org/10.1182/blood-2006-04-019711" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17008546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Histone%20deacetylase%20activities%20are%20required%20for%20innate%20immune%20cell%20control%20of%20Th1%20but%20not%20Th2%20effector%20cell%20function&amp;author=JL%20Brogdon&amp;author=Y%20Xu&amp;author=SJ%20Szabo&amp;author=S%20An&amp;author=F%20Buxton&amp;volume=109&amp;publication_year=2007&amp;pages=1123-1130&amp;pmid=17008546&amp;doi=10.1182/blood-2006-04-019711&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R44">
<span class="label">44.</span><cite>West AC, Christiansen AJ, Smyth MJ, Johnstone RW. The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effects. Oncoimmunology. 2012;1:377–379. doi: 10.4161/onci.18804.</cite> [<a href="https://doi.org/10.4161/onci.18804" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3382866/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22737621/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncoimmunology&amp;title=The%20combination%20of%20histone%20deacetylase%20inhibitors%20with%20immune-stimulating%20antibodies%20has%20potent%20anti-cancer%20effects&amp;author=AC%20West&amp;author=AJ%20Christiansen&amp;author=MJ%20Smyth&amp;author=RW%20Johnstone&amp;volume=1&amp;publication_year=2012&amp;pages=377-379&amp;pmid=22737621&amp;doi=10.4161/onci.18804&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R45">
<span class="label">45.</span><cite>Reddy P, Maeda Y, Hotary K, Liu C, Reznikov LL, Dinarello CA, Ferrara JL. Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. Proc Natl Acad Sci USA. 2004;101:3921–3926. doi: 10.1073/pnas.0400380101.</cite> [<a href="https://doi.org/10.1073/pnas.0400380101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC374345/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15001702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20USA&amp;title=Histone%20deacetylase%20inhibitor%20suberoylanilide%20hydroxamic%20acid%20reduces%20acute%20graft-versus-host%20disease%20and%20preserves%20graft-versus-leukemia%20effect&amp;author=P%20Reddy&amp;author=Y%20Maeda&amp;author=K%20Hotary&amp;author=C%20Liu&amp;author=LL%20Reznikov&amp;volume=101&amp;publication_year=2004&amp;pages=3921-3926&amp;pmid=15001702&amp;doi=10.1073/pnas.0400380101&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R46">
<span class="label">46.</span><cite>Magner WJ, Kazim AL, Stewart C, Romano MA, Catalano G, Grande C, Keiser N, Santaniello F, Tomasi TB. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol. 2000;165:7017–7024. doi: 10.4049/jimmunol.165.12.7017.</cite> [<a href="https://doi.org/10.4049/jimmunol.165.12.7017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11120829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Immunol&amp;title=Activation%20of%20MHC%20class%20I,%20II,%20and%20CD40%20gene%20expression%20by%20histone%20deacetylase%20inhibitors&amp;author=WJ%20Magner&amp;author=AL%20Kazim&amp;author=C%20Stewart&amp;author=MA%20Romano&amp;author=G%20Catalano&amp;volume=165&amp;publication_year=2000&amp;pages=7017-7024&amp;pmid=11120829&amp;doi=10.4049/jimmunol.165.12.7017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R47">
<span class="label">47.</span><cite>Persson M, Andren Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA. 2009;106:18740–18744. doi: 10.1073/pnas.0909114106.</cite> [<a href="https://doi.org/10.1073/pnas.0909114106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2773970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19841262/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20USA&amp;title=Recurrent%20fusion%20of%20MYB%20and%20NFIB%20transcription%20factor%20genes%20in%20carcinomas%20of%20the%20breast%20and%20head%20and%20neck&amp;author=M%20Persson&amp;author=Y%20Andren&amp;author=J%20Mark&amp;author=HM%20Horlings&amp;author=F%20Persson&amp;volume=106&amp;publication_year=2009&amp;pages=18740-18744&amp;pmid=19841262&amp;doi=10.1073/pnas.0909114106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R48">
<span class="label">48.</span><cite>Queimado L, Lopes CS, Reis AM. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors. Genes Chromosomes Cancer. 2007;46:215–225. doi: 10.1002/gcc.20402.</cite> [<a href="https://doi.org/10.1002/gcc.20402" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17171686/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes%20Chromosomes%20Cancer&amp;title=WIF1,%20an%20inhibitor%20of%20the%20Wnt%20pathway,%20is%20rearranged%20in%20salivary%20gland%20tumors&amp;author=L%20Queimado&amp;author=CS%20Lopes&amp;author=AM%20Reis&amp;volume=46&amp;publication_year=2007&amp;pages=215-225&amp;pmid=17171686&amp;doi=10.1002/gcc.20402&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R49">
<span class="label">49.</span><cite>Shao C, Sun W, Tan M, Glazer CA, Bhan S, Zhong X, Fakhry C, Sharma R, Westra WH, Hoque MO, Moskaluk CA, Sidransky D, Califano JA, et al.  Integrated, genome-wide screening for hypomethylated oncogenes in salivary gland adenoid cystic carcinoma. Clin Cancer Res. 2011;17:4320–4330. doi: 10.1158/1078-0432.CCR-10-2992.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-10-2992" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3131484/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21551254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Integrated,%20genome-wide%20screening%20for%20hypomethylated%20oncogenes%20in%20salivary%20gland%20adenoid%20cystic%20carcinoma&amp;author=C%20Shao&amp;author=W%20Sun&amp;author=M%20Tan&amp;author=CA%20Glazer&amp;author=S%20Bhan&amp;volume=17&amp;publication_year=2011&amp;pages=4320-4330&amp;pmid=21551254&amp;doi=10.1158/1078-0432.CCR-10-2992&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R50">
<span class="label">50.</span><cite>Bell A, Bell D, Weber RS, El-Naggar AK. CpG island methylation profiling in human salivary gland adenoid cystic carcinoma. Cancer. 2011;117:2898–2909. doi: 10.1002/cncr.25818.</cite> [<a href="https://doi.org/10.1002/cncr.25818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3123690/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21692051/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=CpG%20island%20methylation%20profiling%20in%20human%20salivary%20gland%20adenoid%20cystic%20carcinoma&amp;author=A%20Bell&amp;author=D%20Bell&amp;author=RS%20Weber&amp;author=AK%20El-Naggar&amp;volume=117&amp;publication_year=2011&amp;pages=2898-2909&amp;pmid=21692051&amp;doi=10.1002/cncr.25818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R51">
<span class="label">51.</span><cite>Ferrarotto R, Mitani Y, Diao L, Guijarro I, Wang J, Zweidler-McKay P, Bell D, William WN, Jr, Glisson BS, Wick MJ, Kapoun AM, Patnaik A, Eckhardt G, et al.  Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors. J Clin Oncol. 2016;35:352–360. doi: 10.1200/JCO.2016.67.5264.</cite> [<a href="https://doi.org/10.1200/JCO.2016.67.5264" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5456373/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27870570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Activating%20NOTCH1%20Mutations%20Define%20a%20Distinct%20Subgroup%20of%20Patients%20With%20Adenoid%20Cystic%20Carcinoma%20Who%20Have%20Poor%20Prognosis,%20Propensity%20to%20Bone%20and%20Liver%20Metastasis,%20and%20Potential%20Responsiveness%20to%20Notch1%20Inhibitors&amp;author=R%20Ferrarotto&amp;author=Y%20Mitani&amp;author=L%20Diao&amp;author=I%20Guijarro&amp;author=J%20Wang&amp;volume=35&amp;publication_year=2016&amp;pages=352-360&amp;pmid=27870570&amp;doi=10.1200/JCO.2016.67.5264&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R52">
<span class="label">52.</span><cite>Borad MJ, Champion MD, Egan JB, Liang WS, Fonseca R, Bryce AH, McCullough AE, Barrett MT, Hunt K, Patel MD, Young SW, Collins JM, Silva AC, et al.  Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma. PLoS Genet. 2014;10:e1004135. doi: 10.1371/journal.pgen.1004135.</cite> [<a href="https://doi.org/10.1371/journal.pgen.1004135" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3923676/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24550739/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genet&amp;title=Integrated%20genomic%20characterization%20reveals%20novel,%20therapeutically%20relevant%20drug%20targets%20in%20FGFR%20and%20EGFR%20pathways%20in%20sporadic%20intrahepatic%20cholangiocarcinoma&amp;author=MJ%20Borad&amp;author=MD%20Champion&amp;author=JB%20Egan&amp;author=WS%20Liang&amp;author=R%20Fonseca&amp;volume=10&amp;publication_year=2014&amp;pages=e1004135&amp;pmid=24550739&amp;doi=10.1371/journal.pgen.1004135&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/5464838/bin/oncotarget-08-32918-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">oncotarget-08-32918-s001.pdf</a><sup> (1.6MB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Oncotarget are provided here courtesy of <strong>Impact Journals, LLC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.18632/oncotarget.16464"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/oncotarget-08-32918.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/5464838/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/5464838/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC5464838%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC5464838/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC5464838/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC5464838/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/28415633/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC5464838/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/28415633/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC5464838/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/5464838/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="QGi9rKIk036haYFOLxceDh43Mu4qGofQsQImdCbShLABl4aP1wAOapXJTmtDJ9Kl">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
